RRM1-induced metastasis suppression through PTEN-regulated pathways.
about
Nicotine promotes tumor growth and metastasis in mouse models of lung cancerOverexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesisAltered gene expression in human cells treated with the insecticide diazinon: correlation with decreased DNA excision repair capacityXPC mRNA level may predict relapse in never-smokers with non-small cell lung cancersUbiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabineMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerLong-term in-vivo tumorigenic assessment of human culture-expanded adipose stromal/stem cellsPredicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of developmentMetabolic genes in cancer: their roles in tumor progression and clinical implicationsRRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.Nucleotide metabolism, oncogene-induced senescence and cancer.Class I(A) PI3Kinase regulatory subunit, p85α, mediates mast cell development through regulation of growth and survival related genesRIN1 is a breast tumor suppressor gene.Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapyA phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy.RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinumERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis.Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Nicotinic acetylcholine receptor signaling in tumor growth and metastasisRibonucleotide reductase large subunit M1 predicts poor survival due to modulation of proliferative and invasive ability of gastric cancer.Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.How close are we to customizing chemotherapy in early non-small cell lung cancer?Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide.Pharmacogenomics: a reality or still a promise?Molecular Markers with Predictive and Prognostic Relevance in Lung CancerProgress in personalizing chemotherapy for bladder cancerCurrent progress of siRNA/shRNA therapeutics in clinical trials.Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy.Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy.Expression of PTEN and KAI1 tumor suppressor genes in pancreatic carcinoma and its association with different pathological factors.Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.Molecular predictors of chemotherapy response in non-small-cell lung cancer.Focal adhesion kinase: a promising target for anticancer therapy.RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patientsThe prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survivalGemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis.Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.
P2860
Q21142724-B319B53B-5E82-400B-B92F-1CB63B358C85Q21245720-2A754C81-116E-4619-B4C0-9B07C246C013Q23922213-A6893364-1896-4F10-9138-6912D46E7299Q28246216-2AD7DDE2-7B67-402E-88EB-FD588E4EA55BQ28540690-62D27C51-4CC1-482B-A492-4DD7C7638536Q29547523-ED155597-4C79-46F2-A909-E0340F5932EEQ30422410-27C5C545-108F-4CF5-B8DF-D7BC6C6AA631Q33247966-7D27D637-C24C-4FC9-8AF3-BA880CCBC280Q33772469-699BB9E1-754E-47EA-8D13-2D58DBB473E1Q33793009-CF3409FE-FE41-4BEB-B4DD-584ED88481EFQ33969333-81BDE464-3AA6-4B80-B55D-532C8421A890Q34124994-A6A2EB17-EEF2-4932-9ED6-7611EDF81321Q34175671-84F348E9-FA34-4A96-AD54-D54951977DCFQ34283650-89E20218-B092-4B41-AF72-E0220AA74EDCQ34610646-23A43035-F8BA-46F3-9504-E117AF215AF4Q34618606-C061B509-0342-45D5-9A84-A8E8EEF782FFQ34625373-18334C1C-B28A-475D-A457-CDDA32827B8AQ34756239-4E1079AC-E3D7-403E-A886-3AA51E76EE19Q34766640-D47DB80E-98D2-4D7D-8C5F-26A1FEA7E156Q34896088-B470C622-DD4D-4CC3-A44D-C23411F99977Q34906454-5BDECD3C-5F00-45CA-9CD7-59F510C1D8DDQ35049696-C7182995-C4CD-4691-BAA3-E87ABAFF189AQ35146944-5833FCEA-C687-4DFB-9BE9-EBAA87E70959Q35242400-7158714F-D54E-41B7-94B0-9B4248A9D38CQ35565186-9AEDE084-4E14-4D6B-81CF-4E0F87C79801Q35763239-17D29B7D-9A7D-44BE-9A0A-466A7F0F8486Q35779460-D101FBF5-A56E-4B64-A506-9F304E78C471Q36071638-157FFA05-3F5C-47EF-A2F7-19741C92D4BAQ36148775-8DCD7066-9322-470D-B4FA-237FBD84588BQ36273435-42E1410F-2EAD-4E32-8873-2D95EBAA098AQ36353167-FA13C196-7027-4D68-A62F-B393A385EC80Q36502768-EAB0515E-E5D5-4F00-B7EC-F24FED66BD13Q36761745-F15AB6BD-B861-4C77-B8C7-683F027B18D2Q36788498-28B09994-2318-4087-9258-7032406CA6A2Q36956729-53BD84BF-1CBB-42D6-8901-FF54E3CA457FQ37148971-7811766A-0EA4-4149-AC75-E07BE4CF04C8Q37158538-EC0283F7-4DE3-43A8-B4C9-69007329345CQ37225452-D094637B-6AED-4AB7-BEBF-A83484BA3DB3Q37360356-BAC11D82-9F21-4982-B9AB-C451B7D7DB61Q37379373-59D57A7A-3D07-4A39-BCBA-76CD19043361
P2860
RRM1-induced metastasis suppression through PTEN-regulated pathways.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@ast
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@en
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@nl
type
label
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@ast
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@en
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@nl
prefLabel
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@ast
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@en
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@nl
P2093
P2860
P356
P1433
P1476
RRM1-induced metastasis suppression through PTEN-regulated pathways.
@en
P2093
Ashish Gautam
Gerold Bepler
Zhan-Rong Li
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206232
P407
P577
2003-04-01T00:00:00Z
P5875
P6179
1000115834